ProQR Therapeutics NV (PRQR.OQ)
PRQR.OQ on NASDAQ Stock Exchange Global Market
12.48USD
2:35pm EST
12.48USD
2:35pm EST
Change (% chg)
$-0.13 (-1.03%)
$-0.13 (-1.03%)
Prev Close
$12.61
$12.61
Open
$12.56
$12.56
Day's High
$12.63
$12.63
Day's Low
$12.35
$12.35
Volume
27,329
27,329
Avg. Vol
101,058
101,058
52-wk High
$24.00
$24.00
52-wk Low
$2.95
$2.95
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 2.96 | -0.179 |
| Jun '18 | 0.97 | -0.230 | |
| Mar '18 | 0.50 | -0.334 | |
| FY 2017 | Dec '17 | 0.51 | -0.393 |
| Sep '17 | 0.33 | -0.416 | |
| Jun '17 | 0.26 | -0.474 | |
| Mar '17 | 0.39 | -0.446 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 3 | 0.90 | 1.60 | 0.00 | -- |
| Quarter Ending Jun-19 | 3 | 0.63 | 1.10 | 0.00 | -- |
| Year Ending Dec-19 | 5 | 3.84 | 7.50 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.31 | -0.25 | -0.39 | -- |
| Quarter Ending Jun-19 | 4 | -0.33 | -0.30 | -0.40 | -- |
| Year Ending Dec-19 | 5 | -1.28 | -1.05 | -1.59 | -1.53 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
| Beta | -- | 1.08 | 0.90 | |
| Price to Sales (TTM) | 79.24 | 49.51 | 6.29 | |
| Price to Book (MRQ) | 2.60 | 10.14 | 5.26 | |
| Price to Tangible Book (MRQ) | 2.61 | 13.78 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
| % Owned Institutions | 54.62 | 3.74 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
| Payout Ratio(TTM) | -- | 7.02 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -55.01 | 206.16 | 12.76 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -64.75 | 48.79 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -11.03 | 75.85 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -24.00 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.07 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
| Current Ratio (MRQ) | 8.22 | 3.50 | 3.08 |
| LT Debt to Equity (MRQ) | 16.54 | 18.65 | 11.38 |
| Total Debt to Equity (MRQ) | 16.54 | 31.33 | 16.12 |
| Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.24 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
| EBITD Margin (TTM) | -3,241.64 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.41 | 12.87 | |
| Operating Margin (TTM) | -3,331.95 | -184.63 | 6.19 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.89 | 8.31 | |
| Pre-Tax Margin (TTM) | -3,376.41 | -175.33 | 7.15 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.69 | 8.61 | |
| Net Profit Margin (TTM) | -3,376.57 | -182.03 | 3.29 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -137.08 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 10,657 | 7,654,547 | 842,388,263 | |
| Net Income/Employee (TTM) | -359,831 | 562,105 | 99,841,601 | |
| Receivable Turnover (TTM) | -- | 6.23 | 5.71 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
| Asset Turnover (TTM) | 0.02 | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -61.65 | 6.39 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.47 | 12.20 | |
| Return on Investment (TTM) | -68.51 | 8.92 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.78 | 15.87 | |
| Return on Equity (TTM) | -75.74 | 10.08 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -43.49 | 150.71 | -- |
| EPS (TTM) % | -87.68 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for ProQR Therapeutics NV
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -13.89 | -16.86 | 11 | 99 |
| 13 Week | -10.58 | -14.93 | 31 | 95 |
| 26 Week | -4.12 | -11.41 | 47 | 98 |
| 52 Week | -34.87 | -44.80 | 27 | 72 |
| YTD | -5.10 | -16.66 | 40 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 77.16% |
| # of Holders: | 86 |
| Total Shares Held: | 29,076,305 |
| 3 Mo. Net Change: | 5,130,206 |
| # New Positions: | 44 |
| # Closed Positions: | 7 |
| # Increased Positions: | 59 |
| # Reduced Positions: | 24 |
| # Net Buyers: | 35 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.